H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)

Go back to H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 103.00 +4.34 (4.40%)
Previous Close $98.66    52 Week High $18.39 
Open $98.86    52 Week Low $6.96 
Day High $104.09    P/E N/A 
Day Low $98.58    EPS $-0.58 
Volume 2,199,506